XML 78 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Event
6 Months Ended
Jun. 30, 2014
Subsequent Event [Abstract]  
Subsequent Event

(18)  Subsequent Event

 

On July 30, 2014, the Company entered into a definitive agreement to acquire Simbionix USA Corporation (“Simbionix”) for $120,000 in cash, subject to customary closing adjustments. Simbionix is a provider of proprietary, high definition, 3D virtual reality surgical simulation, training and educational products for personalized medicine. Simbionix is headquartered in Cleveland, Ohio and has a research and development center in Israel. Under the terms of the agreement, subject to customary closing conditions, the Company will acquire 100% of the outstanding shares of Simbionix.